BLTE
Belite Bio·NASDAQ
--
--(--)
--
--(--)
7.45 / 10
Outperform
Analyst consensus is strongly positive (33% Strong Buy, 66% Buy) and sentiment scores 7.45/10. Fund‑flow rating is good (7.76), with overall and extra‑large inflows positive but small, medium and large segments negative. Momentum remains favorable.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
33%
Buy
67%
Hold
0%
Sell
0%
Strong Sell
0%
Judah FrommerBuy
Date2026-03-03
InstitutionMorgan Stanley
Times predicted2
Historical Win Rate50.0%
Steve SeedhouseBuy
Yi ChenStrong Buy
What is the market sentiment for BLTE?
- BLTE holds a Bullish analyst rating, with 67% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.45/10 (Outperform).
